Published in Circulation on November 17, 2009
Rare Etiology of Bow Hunter's Syndrome and Systematic Review of Literature. J Vasc Interv Neurol (2015) 0.79
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06
Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J Am Coll Cardiol (2013) 2.99
Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol (2010) 2.83
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. J Hypertens (2014) 2.28
Evidence of pre-procedural statin therapy a meta-analysis of randomized trials. J Am Coll Cardiol (2010) 1.76
Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines. J Am Coll Cardiol (2011) 1.62
Limitations of the MEDLINE database in constructing meta-analyses. Ann Intern Med (2010) 1.48
Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension (2012) 1.46
The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials. J Hypertens (2014) 1.45
Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes (2014) 1.41
Aspiration thrombectomy in patients undergoing primary angioplasty: totality of data to 2013. Catheter Cardiovasc Interv (2014) 1.33
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med (2010) 1.17
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Interv Cardiol (2010) 1.14
Development of coronary aneurysm after drug-eluting stent implantation. Ann Intern Med (2007) 1.14
Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am J Med (2009) 1.07
Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials. Am Heart J (2011) 1.04
Is clopidogrel cardiovascular medicine's double-edged sword? Circulation (2006) 1.01
Silent ischemia: clinical relevance. J Am Coll Cardiol (2012) 0.99
The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials. Am Heart J (2008) 0.91
A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol (2006) 0.89
Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials. Am J Cardiovasc Drugs (2007) 0.89
Fractional flow reserve: an updated review. Clin Cardiol (2014) 0.87
The association between NSAID use and colorectal cancer mortality: results from the women's health initiative. Cancer Epidemiol Biomarkers Prev (2012) 0.86
Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention. Am J Cardiol (2007) 0.85
Presence of carotid and peripheral arterial disease in patients with left main disease. Am J Cardiol (2007) 0.84
Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events. Cleve Clin J Med (2013) 0.83
Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women's Health Initiative [WHI]). Am J Cardiol (2012) 0.83
Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention. Am J Cardiol (2012) 0.82
Does the Baseline Coronary Lesion Length Impact Outcomes With IVUS-Guided Percutaneous Coronary Intervention? J Am Coll Cardiol (2016) 0.82
Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines. Clin Cardiol (2011) 0.81
Acute coronary syndrome (unstable angina and non-ST elevation MI). BMJ Clin Evid (2009) 0.80
The optimal treatment of carotid atherosclerosis: a 2008 update and literature review. Postgrad Med (2008) 0.79
Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents. Am Heart J (2008) 0.79
Drug-eluting stents: dual antiplatelet therapy for every survivor? Circulation (2007) 0.77
Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials. Catheter Cardiovasc Interv (2014) 0.77
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes. Am J Cardiol (2006) 0.76
Possible benefit to survival from early invasive strategies in patients with acute coronary syndromes. Ann Intern Med (2008) 0.75
Routine vs selective invasive strategies in acute coronary syndromes. JAMA (2005) 0.75
Designing the ideal risk model for acute coronary syndromes--is simple better than complex? Am Heart J (2007) 0.75
Acute myocardial infarction and drug-eluting stents: a green light for their use or time for measured restraint? Am Heart J (2007) 0.75
Reply: aspiration thrombectomy: an easily forgiven "latecomer". J Am Coll Cardiol (2014) 0.75
Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization. Tex Heart Inst J (2015) 0.75
Paving the coronaries with stents: okay in acute coronary syndromes? Clin Cardiol (2011) 0.75
Treatment of hypertension: lower is better, or is it? Hypertension (2012) 0.75
Non ST-elevation acute coronary syndrome. BMJ Clin Evid (2010) 0.75
Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Indian Heart J (2009) 0.75
The Hidden Players. JACC Cardiovasc Interv (2016) 0.75
The Risk for Stroke With Aspiration Thrombectomy: Procedure or Patient Related?: Insights From a Meta-Analysis. JACC Cardiovasc Interv (2016) 0.75
Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Am J Cardiol (2006) 0.75
Acute myocardial infarction. Am J Med (2005) 0.75
Reply: Mechanical Thrombectomy for Ischemic Stroke. J Am Coll Cardiol (2016) 0.75
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness. Am Surg (2015) 0.75
Reply: Meta-Analysis of Strategies for Patients With Multivessel Disease Undergoing Percutaneous Coronary Intervention: Does the Timing of Staged Procedures Matter? JACC Cardiovasc Interv (2017) 0.75
Bare metal stent thrombosis 13 years after implantation. Cardiovasc Revasc Med (2009) 0.75
Acute myocardial infarction during infusion of liposomal doxorubicin for recurrent breast cancer. Breast J (2010) 0.75
Clopidogrel and coronary stents: risks and benefits. Curr Atheroscler Rep (2008) 0.75
Drug-eluting stents versus bare-metal stents for saphenous vein graft revascularisation: A meta-analysis of randomised trials. EuroIntervention (2017) 0.75
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort. J Hypertens (2017) 0.75
Drug-eluting stents: can we move beyond stent thrombosis? Am Heart Hosp J (2007) 0.75
Understanding and minimizing late thrombosis of drug-eluting stents. Cleve Clin J Med (2007) 0.75